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doi:10.1016/j.ejvs.2011.08.012Abstract Background: To compare eversion (ECEA) and conventional (CCEA) carotid endar-
terectomy from randomised and non-randomised studies.
Methods: Pooled odds ratios (ORs) with 95% confidence intervals (95%CIs) and numbers needed
to treat (NNTs) were appropriately calculated. A sub-analysis was performed on studies
directly comparing ECEA vs. patch CEA (PCEA). Meta-regression analysis was performed to
examine the effect of potentially meaningful patient-related, procedure-related and
definition-related modifiers. Power calculations were also conducted.
Results: A total of 21 studies were deemed eligible (8530 ECEA and 7721 CCEA proce-
dures), seven of which were randomised and 14 non-randomised. ECEA was associated
with significant reduction in perioperative stroke (OR Z 0.46, 95%CI: 0.35e0.62,
NNT Z 68, 95%CI: 56e96), death (OR Z 0.49, 95%CI: 0.34e0.69, NNT Z 100, 95%CI: 85
e185) and stroke-related death (OR Z 0.40, 95%CI: 0.23e0.67, NNT Z 147, 95%CI: 115
e270); the results were replicated at the sub-analysis on PCEA. Concerning long-term
outcomes, ECEA presented with a significant reduction in late carotid artery occlusion
(OR Z 0.48, 95%CI: 0.25e0.90, NNT Z 143, 95%CI: 100e769) and late mortality
(OR Z 0.76, 95%CI: 0.61e0.94, NNT Z 40, 95%CI: 25e167); the sub-analysis on PCEA repli-
cated only the finding on late mortality. Meta-regression analysis did not point tolar Surgery; ESVS, European Society for Vascular Surgery; NASCET, North American Symptomatic
eversion carotid endarterectomy; CCEA, conventional carotid endarterectomy; PCEA, patch carotid
ure carotid endarterectomy; MOOSE, Meta-analysis of Observational Studies in Epidemiology; TIA,
s ratio; CI, confidence intervals; RD, risk difference; NNT, number needed to treat; MeH, Man-
rtery; ICA, internal carotid artery; ECA, external carotid artery.
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752 C.N. Antonopoulos et al.significant effects mediated by the examined modifiers. Power calculations suggested
adequate statistical power.
Conclusions: ECEA compared to CCEA may be associated with a lower incidence in both
short-term and long-term outcomes, which does not seem to be hampered by potentially
meaningful modifiers.
ª 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights
reserved.Introduction
Carotid artery atherosclerosis has puzzled surgeons formany
decades regarding the appropriate management of symp-
tomatic and asymptomatic patients. However, it was not
until recently that guidelines were published for the optimal
treatment of carotid artery disease.1 In symptomatic
patientswithmoderate to severe carotid stenosis (more than
50%), the Society for Vascular Surgery (SVS) recommends
carotid endarterectomy plus optimal medical therapy; in
asymptomatic patients with moderate to severe carotid
stenosis (60%), SVS recommends carotid endarterectomy
plusmedicalmanagement, as long as the perioperative risk is
low.2 According to current Grade A recommendations of the
European Society for Vascular Surgery (ESVS), operative
intervention is the treatment of choice for symptomatic
patients with>70% and probably with>50% (North American
Symptomatic Carotid Endarterectomy Trial; NASCET)
stenosis; it can be recommended for asymptomatic men
younger than 75 years with 70e99% (NASCET) stenosis,
provided that the risk of surgery is less than 3%.3
Surgical options comprise conventional (CCEA) and
eversion carotid endarterectomy (ECEA). The first includes
a standard longitudinal carotid arteriotomy with or without
patch angioplasty,4 whereas the second encompasses an
oblique transection and eversion of internal carotid artery
(ICA) and reimplantation of the latter into the common
carotid artery.5,6 Noticeably, concerning CCEA the most
recent ESVS guidelines state that carotid patch angioplasty
is preferable to primary closure.3
The most recent meta-analysis on the field, comparing
ECEA with CCEA, has been published almost 10 years ago by
the Cochrane Collaboration;7 notably, the aforementioned
meta-analysis had included only randomised studies. Since
then, one additional randomised study has appeared,8
whereas the considerable pool of non-randomised studies
has not yet been evaluated. The Cochrane meta-analysis
had pointed to the equivalence of ECEA with CCEA in
terms of perioperative death, stroke, myocardial infarc-
tion, cranial nerve injuries, neck haematoma and carotid
occlusion, as well as regarding late stroke events; notice-
ably, a borderline superiority of ECEA had emerged con-
cerning late re-stenosis rates. Of interest, the Cochrane
Review had not addressed early carotid artery stenosis,
perioperative transient ischaemic attacks (TIAs), late death
and late occlusion.
In the light of the above, this meta-analysis aims to
provide a comprehensive approach to the existing litera-
ture, synthesising the bulk of data coming from both
randomised and non-randomised studies. Special attentionwas paid to separate analyses on ECEA vs. patch CCEA
(PCEA). Given that many previously undiscovered patient-
related, procedure-related and definition-related modifiers
may interfere with the ECEA vs. CCEA comparison,
a detailed meta-regression analysis was planned to examine
their putative effects. Given that discrepancies between
meta-analyses may also entail differences in the underlying
statistical power, comparative power calculations were
provided.MethodsData collection
The presentmeta-analysis was conducted in accordancewith
the recommendations of the Meta-analysis of Observational
Studies in Epidemiology (MOOSE) group and approved by the
Local Ethics Committee.9 An extensive combined compu-
terised and manual systematic database search of medical
literature was performed. Publications were retrieved from
electronic search engines (Medline, Embase, Scopus, Google
Scholar, Ovid and theCochrane Library) and all reference lists
were searched for further relevant studies.
Types of studies, search terms, eligibility and
exclusion criteria
Publications of interest included randomised and non-
randomised studies, editorials, systematic reviews, meta-
analyses, short papers, letters to the editor, personal views
and special communications. Mesh terminology used for
search purposes were ‘carotid’ [All Fields] AND ‘endarter-
ectomy’[All Fields] AND (‘eversion’[All Fields] OR ‘con-
ventional’[All Fields] OR ‘standard’[All Fields] OR ‘open’[All
Fields] OR ‘primary closure’[All Fields] OR ‘patch’[All Fields]
OR ‘division’[All Fields]). We identified all studies that
evaluated short-term and late-term outcomes (see below)
after both ECEA and CCEA (primary; PCCEA or patch closure
after longitudinal arteriotomy) in patients with carotid
stenosis. Given that ECEA was first introduced by DeBakey
et al. in 1959,10 scientific papers published between May
1959 and 30 December 2010 were examined. No restrictions
concerning gender, age, degree of stenosis and unilateral/
bilateral procedures were adopted. Exclusion criteria were
the following: case reports, studies presenting data only for
CCEA (case series) and multiple publications on the over-
lapping populations. Data were independently extracted and
analysed by three reviewers (AC, KJ and ST) and inter-
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consensus.
Data extraction
Data extracted from eligible studies included authors,
study year, journal and type of study (randomised or non-
randomised). From each study, characteristics that were
extracted for both groups of conventional and eversion
endarterectomy were 1) descriptive study characteristics:
study size with number of patients and interventions (total
and numbers for each group separately), indications for
surgery (number of symptomatic and asymptomatic
patients; 2) demographic variables: mean age and sex
(proportion of males); 3) mean length of follow-up
(months); and 4) technical variables: type of anaesthesia,
use of cerebral monitoring method, operative technique,
type of patch when used, use of shunt (proportion of
patients), mean clamping time (min) and mean operative
time (min).
Furthermore, short- and long-term outcomes were
extracted for each group, where possible. Short-term
outcomes were defined as events occurring within 30
days following the operation and they were 1) residual
carotid artery stenosis (lumen reduction noted at the
proximal or distal end of the endarterectomised site); 2)
early carotid artery occlusion (complete closure of the
carotid artery); 3) perioperative stroke (any acute
neurological deficit lasting more than 24 h including
disabling or non-disabling, contralateral or ipsilateral
events); 4) perioperative TIA (transient neurological
dysfunction with complete recovery within 24 h); 5)
overall perioperative death (death of any origin); 6) per-
ioperative stroke-related death (any death due to stroke);
7) cranial nerve injury (transient or permanent cranial
nerve impairment); 8) myocardial infarction (fatal and
non-fatal); and 9) neck haematoma. Long-term outcomes,
defined as events occurring after the periprocedural
period (the latter surpassing 30 days), included 1) recur-
rent carotid artery stenosis (recurrent luminal diameter
narrowing >50%), 2) late carotid artery occlusion, 3) late
stroke and 4) late mortality (definitions similar to these of
short-term outcomes).
Data synthesis and power calculations
Analysis of all measured outcomes was performed per
artery rather than per patient, as this was the standard
practice of most studies included. However, patient-
related variables (death, stroke, TIA, stroke-related death
and myocardial infarction), either as short-term or long-
term outcomes, were treated with analysis per patient.
This approach to data is consistent with Cochrane Collab-
oration’s meta-analysis on ECEA vs. CCEA, presenting data
only for randomised studies.7 Based on the available
numbers, odds ratios (ORs) were appropriately calculated
from 2  2 tables; an OR<1 favoured ECEA as the
comparison format was ‘ECEA vs. CCEA’.
A pooled estimate of ORs, together with the corre-
sponding confidence intervals (95%CIs), was calculated. A
fixed effects model (Peto method) or a random-effectsmodel (ManteleHaenszel method) was used for non-
heterogeneous or heterogeneous data, respectively. Test
for overall effect was applied (Z-test) and statistical
significance level was set to p < 0.05. Data were graphed as
forest plots.
Apart from the overall analysis, sub-analyses were per-
formed on the subsets of randomised and non-randomised
studies; the appropriate Z-test was performed to examine
whether pooled ORs derived from randomised or non-
randomised studies differed from each other. An addi-
tional sub-analysis was performed on the subset of studies
directly comparing ECEA vs. PCEA. Calculation of pooled
ORs was performed using Review Manager (RevMan v5,
Cochrane Collaboration, Copenhagen, Denmark).
In addition, event rates for ECEA, CCEA and PCEA
among all studied outcomes were calculated and the
numbers needed to treat (NNTs) with 95%CIs for the
comparisons ECEA vs. CCEA and ECEA vs. PCEA were esti-
mated post hoc11 based on statistically significant ORs,
using ‘metannt’ command (STATA Corp., College Station,
TX, USA). The NNT was equal to 1/(CCEA group event rate
e ECEA group event rate) or 1/(PCEA group event rate e
ECEA group event rate), respectively. In our case, NNT
indicated the number of patients that would have to
undergo ECEA in order to prevent one morbidity or
mortality-related event.Heterogeneity, publication bias, meta-regression
analysis and power calculations
Heterogeneity among studies was estimated by chi-square
test and Cochran Q score (reported as I2 and representing
the percent value of the heterogeneity) with corresponding
p values. Funnel plots for asymmetry were formed and
corresponding Egger’s regression tests were used as
a measure of estimating publication bias and assessing its
impact on the analysis.
Meta-regression analysis was performed post hoc in case
of statistically significant differences, so as to examine
whether the documented differences were modified by
potentially meaningful predictors. The Cochrane Handbook
for Systematic Reviews12 dictates that meta-regression
should only be performed in case of more than 10 studies.
As a result, meta-regression was conducted only at the
overall analysis (encompassing the totality of randomised
and non-randomised studies) to avoid the performance of
numerous low power tests; evidently, meta-regression
analysis was spared at the sub-analysis on ECEA vs. PCEA
for reasons of power.
An additional doseeresponse meta-regression analysis
focussed specifically on recurrent carotid artery stenosis and
late carotid artery occlusion, as eligible studies presented
distinct ORs along with various degrees (% percentages) of
carotid stenosis. The doseeresponse analysis assessed the
association between the degree of stenosis and the corre-
sponding OR in the individual studies. Specifically, in case of
category a to b, the midpoint was allocated as the indepen-
dent variable of the meta-regression model, as appro-
priate.13 Meta-regression analysis, as well as evaluation of
publication bias, was performed with STATA 11.1 software.
Furthermore, in order to compare the power of the present
754 C.N. Antonopoulos et al.meta-analysis with the previous one,7 power calculations
were performed using the generalised power calculations
STATA (‘powercal’) command;14 separate calculations were
performed on the subsets of randomised and non-randomised
studies.
Results
Characteristics of eligible studies
As shown in the flow diagram (Fig. 1), after review of the
abstracts, 27 articles were eventually deemed relevant out
of a total of 2132 articles of interest; out of these, in theFigure 1 Flow chart presenting tsubsequent detailed evaluation, five articles were excluded,
because they were found to have been performed on
mutually overlapping populations.15e19 In particular, two
non-randomised studies by Ballotta et al.15,16 had to be
excluded, as they overlapped with the eligible two rando-
mised studies by the same research team;4,20 similarly, the
studies by Mehta et al.18,19 and the study by Darling et al.17
overlapped with the larger, eligible study by Shah et al.21
Taken as awhole, 22 articleswere deemedeligible for this
meta-analysis; seven used a randomised design4,8,20,22e25
and 15 used a non-randomised design.5,21,26e38 The 22 arti-
cles corresponded to 24 studies, as two articles29,32 pre-
sented data for both ECEA vs. PCEA and ECEA vs. PCCEA.
Specifically, three randomised8,23,24 and six non-randomisedhe selection of eligible studies.
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PCCEA), four randomised4,20,22,25 and eight non-randomised
studies26,28,30,31,33,34,37,38 compared ECEA with PCEA and
three non-randomised studies compared ECEA vs.
PCCEA.5,29,32 A total of 15,034 patients underwent 16,251
CEA procedures (8530 ECEA; 5540 PCEA; 1499 PCCEA and 682
CCEA in which the distinction between PCEA and PCCEA was
not made). Recruitment period, mean follow-up (months),
number of patents and interventions, definition of carotid
stenosis and proportion (% percentage) of PCEA among CCEA
are provided in Table 1. Further details of eligible studies
with respect to proportion (%) of symptomatic patients,
mean age of patients, proportion of males (%), patch type,
type of anaesthesia, cerebral monitoring method, propor-
tion of shunt use (%), mean operative time (min), mean
carotid clamping time (min), exclusion criteria, random-
isation method for randomised studies, preoperative evalu-
ation, indications of surgery and details on ECEA are
presented in Supplemental Table S1.Meta-analysis
Short-term outcomes
ECEA versus CCEA
ECEA as compared with CCEA was associated with signifi-
cant reduction in perioperative stroke (OR Z 0.46, 95%CI:
0.35e0.62, Fig. 2) in both randomised and non-randomised
studies. The respective NNT was equal to 68 (95%CI:
56e96); in other words, for every 68 patients being treated
with ECEA (instead of CCEA), one stroke event might be
avoided (Supplemental Table S5).
With respect to perioperative death and stroke-related
death, the pooled effect estimate was once again in favour
of ECEA (OR Z 0.49, 95%CI: 0.34e0.69, NNTZ 100, 95%CI:
85e185, Fig. 3) and OR Z 0.40, 95%CI: 0.23, 0.67,
NNT Z 147, 95%CI: 115e270), but the difference was
confined to non-randomised studies (OR Z 0.45, 95%CI:
0.30, 0.67 and OR Z 0.35, 95%CI: 0.19, 0.64).
No significant difference was observed between ECEA
and CCEA in the risk for residual carotid artery stenosis,
early carotid artery occlusion, perioperative TIA, cranial
nerve injury, myocardial infarction or neck haematoma.
Details regarding pooled ORs in all examined outcomes are
provided in Table 2.
Sub-analysis on ECEA versus PCEA
The sub-analysis comparing ECEA versus PCEA replicated
the findings of the overall analysis regarding perioperative
stroke, as the latter was significantly reduced after ECEA
(ORZ 0.39, 95%CI: 0.26, 0.61, NNTZ 61, 95%CI: 49e94) in
both randomised and non-randomised studies.
With respect to perioperative TIA, the pooled effect
estimate was in favour of ECEA (OR Z 0.55, 95%CI:
0.33e0.91, NNT Z 78, 95%CI: 52e400), due to statistically
significant reduction after ECEA in randomised studies
(OR Z 0.36, 95%CI: 0.19e0.69). Similarly to the overall
analysis, perioperative death presented less frequently in
ECEA compared to PCEA (OR Z 0.40, 95%CI: 0.24e0.66,
NNT Z 82, 95%CI: 65e145); the difference reached statis-
tical significance in non-randomised studies and a finding of
borderline significance emerged in the subset ofrandomised trials. Regarding perioperative stroke-related
death, the findings of the overall analysis were replicated,
as ECEA was associated with a significantly reduced risk
(ORZ 0.34, 95%CI: 0.16e0.69, NNTZ 110, 95%CI: 87e238),
due to non-randomised studies (OR Z 0.35, 95%CI:
0.16e0.76).
No significant differences were observed between ECEA
and PCEA with respect to residual carotid artery stenosis,
early carotid artery occlusion, cranial nerve injury,
myocardial infarction and neck haematoma.
Long-term outcomes
ECEA presented with a significant reduction in late carotid
artery occlusion compared to CCEA (OR Z 0.48, 95%CI:
0.25e0.90, NNT Z 143, 95%CI: 100e769, Fig. 4), due to
randomised studies (OR Z 0.24, 95%CI: 0.08e0.72). Simi-
larly, the pooled effect estimate was in favour of ECEA in
late mortality (OR Z 0.76, 95%CI: 0.61, 0.94, NNT Z 40,
95%CI: 25e167, Fig. 5), but only non-randomised studies
showed a significant association (OR Z 0.66, 95%CI:
0.45e0.94). ECEA and CCEA presented with similar risk for
recurrent carotid stenosis and late stroke (Table 2).
The sub-analysis on studies comparing ECEA versus PCEA
replicated the significant reduction in late mortality
(OR Z 0.64, 95%CI Z 0.44, 0.92, NNT Z 26, 95%CI:
16e119), particularly evident in non-randomised studies
(OR Z 0.36, 95%CI: 0.18e0.72). In accordance with the
overall analysis, ECEA and PCEA presented with similar risk
for recurrent carotid stenosis, late carotid occlusion and
late stroke (Table 2).
Meta-regression analysis
Detailed results of meta-regression analysis are presented
in Supplemental Table S2. No significant effects were
demonstrated with respect to the examined patient-
related, procedure-related and definition-related modi-
fiers. In addition, the elaborate doseeresponse meta-
regression analysis did not point to significant association
between the degree of stenosis and the corresponding OR in
the individual studies (exp (b) Z 1.00, p Z 0.83); the
detailed ORs and 95%CIs pertaining to various degrees (%
percentages) of recurrent carotid artery stenosis and late
carotid artery occlusion are presented in Supplemental
Table S3.
Power calculations
The power calculations regarding the Cochrane Collabora-
tion meta-analysis,12 as well as the present meta-analysis,
are presented in Supplemental Table S4. The estimated
power of the Cochrane Collaboration meta-analysis ranged
between 4.75% and 20.72%, whereas the estimated power
of the current meta-analysis ranged between 61.26% and
99.96%, depending on the outcomes examined.
Discussion
The main findings of this meta-analysis pertain to the
potential superiority of ECEA in terms of perioperative
stroke, death and stroke-related death, as well as late
Table 1 Descriptive studies characteristics.
First author Year Country Type
of study
Recruitment
period
Mean follow-up
(months)
Patients
(n)
Interventions
(n)
Type of intervention
(number of
interventions)
Definition of
carotid stenosis
outcome
% Patch
(PCEA/CCEA)
Ballotta 2000 Italy RS NR 40 (6e69)a 68 136 ECEA (68) >50% 100.0
PCEA (68)
Ballotta 1999 Italy RS 5 years 34 (1e69)a 310 336 ECEA (169) >50% 100.0
PCEA (167)
Balzer 1998 Germany RS 1991e1992 24 564 564 ECEA (286) NR 100.0
PCEA (278)
Brothers 2005 USA NRS 1997e2003 36 200 200 ECEA (100) >50% 100.0
PCEA (100)
Cao 1998,
2000
Italy RS 1994e1997 33 (12e55)a 1353 1353 ECEA (678) >50% 38.0
PCEA (256)
PCCEA (419)
Cao 1997 Italy NRS 1992e1994 28 (12e54)a 469 514 ECEA (274) >50% 49.2
PCEA (118)
PCCEA (122)
Crawford 2007 USA NRS 1995e2005 55 (12e140)a 290 290 ECEA (135) >50% 100.0
PCEA (155)
Economopoulos 1999 USA NRS 1994e1998 16 (0e48)a 173 190 ECEA (33) >80% 90.5
PCEA (142)
PCCEA (15)
Entz 1997 Hungary NRS 1991e1993 36 1393 1454 ECEA (739) NR 100.0
PCEA (715)
Goodney 2010 USA NRS 2003e2008 13 (1e35)a 2981 2981 ECEA (370) >50% 91.0
PCEA (2376)
PCCEA (235)
Green 2000 USA NRS 1998 12 274 274 ECEA (107) >50% 100.0
PCEA (167)
Katras 2001 USA NRS 1997e2000 23 (6e42)a 296 322 ECEA (118) >60% 52.5
PCEA (107)
PCCEA (97)
Kieny 1993 France NRS 1987 44 362 368 ECEA (212) >50% 0.0
PCCEA (156)
Littooy 2004 USA NRS 1998e2002 17 (3e42)a 189 189 ECEA (64) >50% 100.0
PCEA (125)
Markovic 2008 Serbia RS 2000e2003 38 (24e52)a 201 201 ECEA (103) >50% 78.6
PCEA (77)
PCCEA (21)
Peiper 1999 Germany NRS 1994, 1996 31 727 863 ECEA (475) >50% 100.0
PCEA (388)
Radak 2000 Yugoslavia NRS 1991e1998 56 (6e92)a 2469 2806 ECEA (2124) >50% NR
PCEA, PCCEA (682)
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Eversion versus Conventional Carotid Endarterectomy 757mortality and late carotid artery occlusion. Concerning only
randomised studies, these findings were replicated in terms
of perioperative stroke, recurrent carotid artery stenosis
and late carotid artery occlusion. This kaleidoscope of
findings may represent significant advancement in the
understanding of ECEA when compared to the previous
Cochrane meta-analysis.7 The elaborate meta-regression
analysis with a variety of clinically meaningful, possible
modifiers pointed to lack of significant effects, which may
allow the generalisation of findings upon various subsets of
patients with ranging values of modifiers. Accordingly, the
sub-analysis on PCEA replicated the results of the overall
analysis, although PCEA has been demonstrated as prefer-
able over primary closure;39 this may further substantiate
the superiority of ECEA versus any CCEA procedure,
including PCEA.
The most significant findings of the present meta-analysis
pertain to the triad perioperative stroke-death-stroke-
related death; taken as a whole, this pattern may well
entail clinical implications. In simple clinical terms, it seems
that for every 68 patients being treatedwith ECEA (instead of
CCEA), one stroke eventmight be avoided.Of note, statistical
significance was reached in both subsets of studies (rando-
mised and non-randomised) concerning perioperative stroke,
whereas the fact that significance was not reached in rand-
omised studies regarding perioperative death and stroke-
related death seems rather to be due to lack of statistical
power. Interestingly enough, close inspection of individual
studies may reveal that, although nearly all studies had
pointed to a mild protective effect of ECEA in terms of peri-
operative stroke and death, the latter seems to have gained
sufficient power only at the meta-analytical level.
Regarding late-term outcomes, the superiority of ECEA in
terms of mortality persisted, whereas any beneficial effects
concerning stroke vanished. On the other hand, concerning
late carotid artery occlusion, ECEA seemed to confer superior
patency; interestingly enough, a compatible finding of
borderline statistical significance emerged as far as recurrent
carotid stenosis is concerned. Worthy of note, these findings
seemed to stem from the randomised studies, although the
corresponding Z-tests did not reveal significant deviations
between randomised and non-randomised studies. In simple
terms, the superiority of ECEA might be translated as for
every 143patients being treatedwith ECEA (instead of CCEA),
one late carotid artery occlusion might be avoided.
Regarding possible mechanisms underlying the superi-
ority of ECEA in terms of late carotid artery occlusion and
re-stenosis, it has been postulated that myointimal hyper-
plasia15 seems to be reduced when one oblique suture line
is used (ECEA) instead of prosthetic material and two suture
lines.4,27e29 Moreover, evaluation of CCEA versus ECEA with
flow measurements in terms of diameter, strain and stiff-
ness has led to the ascertainment that the arteries oper-
ated by the second technique seem closer to a non-
operated artery.40 On the other hand, ECEA may offer
a great vision of a more lengthy part of the interior ICA wall
and thus distal end points may well be visualised,19,35
maintaining the original streamlined anatomy of the
artery.21 Along with the complete mobilisation and trans-
verse reimplantation of the ICA, ECEA seems to maintain
the amplitude of carotid’s ostium;15 any kinking or coiling
of the ICA can be removed21 and perianastomotic
Figure 2 Forest plot presenting the meta-analysis based on ORs for the association between Eversion Carotid Endarterectomy vs.
Conventional Carotid Endarterectomy and risk for perioperative stroke. ORs in the individual studies are presented as squares with
95%CIs presented as extending lines. The pooled OR with its 95%CI is depicted as a diamond.
758 C.N. Antonopoulos et al.hypercompliant zone, which is often described after the
conventional technique, can be easily avoided.34 Further-
more, the incision at a wider portion, which is the bulb,
may be associated with decreased possibility for re-
stenosis.29 Taken as a whole, all the above aspects may
have contributed at a certain degree to the reduced late
re-stenosis, occlusion and, potentially, mortality after
ECEA.
The comparison of CCEA and ECEA may essentially
integrate a variety of potential inherent patient-related, as
well as procedure-related and definition-related modifiers.
Impressively enough, the detailed meta-regression analysis
did not suggest that any of the above numerous modifiers
examined could affect the generalisability of the present
findings. In simpler terms, the documented ORs did not
seem to be modified by otherwise clinically meaningful
parameters, such as male gender, age, patch usage, shunt
usage, operative time, carotid clamping time and definition
of stenosis. It thus seems that all these parameters may
have affected both ECEA and CCEA at a comparable
fashion, without changing their demonstrated differences.
In addition, it is worth mentioning that the elaboratedoseeresponse meta-regression analysis revealed that the
documented differences between ECEA and CCEA in terms
of late re-stenosis/occlusion were not modified by the
exact degree (percentage) of stenosis.
A major concern when combining randomised and non-
randomised studies pertains to the existence of biases in
the latter subset of studies, which may at a certain level
skew the overall results; indeed, non-randomised studies
are generally considered of lower quality than randomised
ones.41 It is worth reporting in our dataset that the
appropriate Z-tests examining the differences between
randomised and non-randomised studies did not reveal
significant discrepancies, as a rule. This may clearly support
pooling of all eligible studies, irrespective of random-
isation, as the latter did not seem to introduce any major
bias in favour of any procedure. As a result, the quantita-
tive synthesis of all studies seems to have furnished the
advantage of high statistical power without being
hampered by methodological concerns. This is in line with
a recent methodological article supporting the incorpora-
tion of non-randomised comparative studies into the meta-
analyses of surgical procedures.42
Figure 3 Forest plot presenting the meta-analysis based on ORs for the association between Eversion Carotid Endarterectomy vs.
Conventional Carotid Endarterectomy and risk for perioperative death. ORs in the individual studies are presented as squares with
95%CIs presented as extending lines. The pooled OR with its 95%CI is depicted as a diamond.
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which are related to the estimation of measurable effect
estimates of the short- and long-term outcomes after ECEA
versus CCEA, this study has limitations which may actually
reflect the ones of the individual studies included. Although
we have tried to analyse all possible modifiers in the meta-
regression analysis that could be extracted from the orig-
inal publications, it is probable that not all possibly rele-
vant modifiers were eventually covered, due to lack of
information from the original publications, that is, the
effect of a learning curve or the type of anaesthesia.
Furthermore, the use of a temporary intra-arterial shunt in
ECEA is more problematic and in a majority of cases avoi-
ded. Although the use of a shunt was a non-significant
modifier in this study for both ECEA and CCEA, this may be
due to a lower incidence of shunt use with ECEA.
It should also be noted that, although NNT analysis has
shown benefit of ECEA vs. CCEA, this was based on relatively
large absolute numbers, indicating that the benefit,
although statistically significant, may be clinically small.
Additionally, despite the fact that the appropriate Z-testsexamining the differences between randomised and non-
randomised studies did not reveal significant discrepancies
in statistically significant terms, qualitative differences
between the two types of studies cannot be ruled out.
A finding that deserves cautious interpretation is the
decreased late mortality after ECEA without a concomitant
decrease in late stroke. Although speculation about the
reasons for this discrepancy is beyond the scope of this
meta-analysis, several assumptions can be made. There
might have been some potentially confounding factors that
could not be extracted from the original publications, such
as a different degree of atherosclerotic burden among the
two groups, reflecting a different risk factor profile.
In conclusion, the current meta-analysis indicates that
ECEA may be associated with a lower incidence in both
short-term (perioperative stroke, perioperative mortality
and stroke-related mortality) and long-term (late mortality
and late carotid artery occlusion) outcomes. The superi-
ority of ECEA seems fairly substantiated as possibly mean-
ingful modifiers could not interfere with the set of
documented, sizeable findings.
Table 2 Pooled ORs and 95%CIs for the examined outcomes. Bold cells denote statistically significant ORs.
Short-term
outcome
Comparison Randomized studies Non-Randomized studies Total
Number
of studies
Subtotal
OR
Heterogeneity Number
of
studies
Subtotal
OR
Heterogeneity Number
of studies
Total terogeneity Analysis
Method
Publication
bias
Test for
subgroup
differences
coef p
value
z-test p
value
Residual
Carotid
Artery
Stenosis
ECEA
vs CCEA
2 0.14
[0.02,
1.16],
P Z 0.07
I2 Z 0%,
P Z 0.79
4 1.18
[0.64,
2.20],
P Z 0.60
I2 Z 6%,
P Z 0.35
6 0.95
[0.42,
2.15],
P Z 0
Z 30%,
Z 0.22
MeH
Random
0.6 0.66 1.97 0.05
ECEA
vs PCEA
2 0.14
[0.02,
1.16],
P Z 0.07
I2 Z 0%,
P Z 0.79
4 1.18
[0.64,
2.20],
P Z 0.60
I2 Z 6%,
P Z 0.35
6 0.95
[0.42,
2.15],
P Z 0
Z 30%,
Z 0.22
MeH
Random
0.6 0.66 1.97 0.05
Early
Carotid
Artery
occlusion
ECEA
vs CCEA
6 0.85
[0.41,
1.75],
P Z 0.66
I2 Z 0%,
P Z 0.73
4 0.50
[0.24,
1.04],
P Z 0.06
I2 Z 47%,
P Z 0.15
10 0.65
[0.39,
1.10],
P Z 0
Z 1%,
Z 0.42
Peto
Fixed
2.47 0.04 1.01 0.31
ECEA
vs PCEA
4 0.74
[0.32,
1.70],
P Z 0.48
I2 Z 0%,
P Z 0.66
2 1.36
[0.33,
5.49],
P Z 0.67
Not
applicable
6 0.87
[0.42,
1.77],
P Z 0
Z 0%,
Z 0.71
Peto
Fixed
7.4 0.76 0.73 0.47
Perioperative
Stroke
ECEA
vs CCEA
6 0.56
[0.33,
0.96],
P Z 0.03
I2 Z 51%,
P Z 0.08
13 0.43
[0.30,
0.60],
P< 0.001
I2 Z 0%,
P Z 0.80
19 0.46
[0.35
0.62]
P<
Z 1%,
Z 0.44
Peto
Fixed
0.8 0.08 0.81 0.42
ECEA
vs PCEA
4 0.27
[0.11,
0.65],
P Z 0.003
I2 Z 0%,
P Z 0.62
9 0.45
[0.27,
0.73],
P Z 0.002
I2 Z 0%,
P Z 0.70
13 0.39
[0.26
0.61]
P<
Z 0%,
Z 0.77
Peto
Fixed
0.6 0.27 0.98 0.33
Perioperative
TIA
ECEA
vs CCEA
5 0.49
[0.23,
1.05],
P Z 0.07
I2 Z 31%,
P Z 0.321
8 0.85
[0.44,
1.66],
P Z 0.63
I2 Z 41%,
P Z 0.10
13 0.67
[0.41,
1.07],
P Z 0
Z 34%,
Z 0.11
MeH
Random
1.08 0.18 1.07 0.28
ECEA
vs PCEA
3 0.36
[0.19,
0.69],
P Z 0.002
I2 Z 0%,
P Z 0.88
5 1.07
[0.47,
2.45],
P Z 0.87
I2 Z 0%,
P Z 0.50
8 0.55
[0.33
0.91]
P Z 0
Z 10%,
Z 0.35
Peto
Fixed
1.29 0.14 2.04 0.04
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.02
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P
Perioperative
Death
ECEA
vs CCEA
6 0.67
[0.31,
1.42],
P Z 0.29
I2 Z 41%,
P Z 0.15
13 0.45
[0.30,
0.67],
P< 0.001
I2 Z 0%,
P Z 1.00
19 0.49
[0.34,
0.69],
P< 0.001
I2 Z 0%,
P Z 0.83
Peto
Fixed
0.13 0.74 0.91 0.36
ECEA
vs PCEA
4 0.35
[0.11,
1.09],
P Z 0.07
I2 Z 0%,
P Z 0.55
9 0.41
[0.23,
0.72],
P Z 0.002
I2 Z 0%,
P Z 0.95
13 0.40
[0.24,
0.66],
P< 0.001
I2 Z 0%,
P Z 0.97
Peto
Fixed
0.21 0.6 0.24 0.81
Perioperative
Stroke-related
Death
ECEA
vs CCEA
5 0.61
[0.20,
1.81],
P Z 0.37
I2 Z 69%,
P Z 0.02
11 0.35
[0.19,
0.64],
P< 0.001
I2 Z 0%,
P Z 0.98
16 0.40
[0.23,
0.67],
P< 0.001
I2 Z 13%,
P Z 0.32
Peto
Fixed
0.57 0.29 0.87 0.39
ECEA
vs PCEA
3 0.28
[0.05,
1.66],
P Z 0.16
I2 Z 0%,
P Z 0.66
9 0.35
[0.16,
0.76],
P Z 0.009
I2 Z 0%,
P Z 0.97
12 0.34
[0.16,
0.69],
P Z 0.003
I2 Z 0%,
P Z 0.99
Peto
Fixed
0.53 0.09 0.23 0.82
Cranial Nerve
Injury
ECEA
vs CCEA
5 0.61
[0.30,
1.26],
P Z 0.18
I2 Z 45%,
P Z 0.12
7 1.11
[0.69,
1.80],
P Z 0.67
I2 Z 38%,
P Z 0.14
12 0.90
[0.60,
1.34],
P Z 0.60
I2 Z 44%,
P Z 0.05
MeH
Random
1.1 0.14 1.36 0.17
ECEA
vs PCEA
3 0.34
[0.10,
1.18],
P Z 0.09
I2 Z 53%,
P Z 0.12
5 1.51
[1.08,
2.11],
P Z 0.02
I2 Z 0%,
P Z 0.87
8 0.98
[0.52,
1.84],
P Z 0.95
I2 Z 49%,
P Z 0.05
MeH
Random
0.8 0.35 2.29 0.02
Myocardial
Infarction
ECEA
vs CCEA
3 0.98
[0.31,
3.04],
P Z 0.97
I2 Z 0%,
P Z 0.72
5 0.85
[0.37,
1.94],
P Z 0.70
I2 Z 1%,
P Z 0.40
8 0.89
[0.46,
1.74],
P Z 0.73
I2 Z 0%,
P Z 0.69
Peto
Fixed
0.17 0.82 0.2 0.84
ECEA
vs PCEA
1 0.49
[0.05,
4.76],
P Z 0.54
Not
applicable
3 0.34
[0.06,
1.90],
P Z 0.22
I2 Z 0%,
P Z 0.50
4 0.39
[0.10,
1.53],
P Z 0.18
I2 Z 0%,
P Z 0.69
Peto
Fixed
0.7 0.86 0.25 0.80
Neck
Hematoma
ECEA
vs CCEA
4 0.72
[0.40,
1.32],
P Z 0.29
I2 Z 52%,
P Z 0.10
6 1.26
[0.71,
2.24],
P Z 0.43
I2 Z 42%,
P Z 0.13
10 0.97
[0.65,
1.45],
P Z 0.87
I2 Z 45%,
P Z 0.06
MeH
Random
0.76 0.57 1.32 0.19
ECEA
vs PCEA
3 0.56
[0.34,
0.92],
P Z 0.02
I2 Z 0%,
P Z 0.59
4 1.61
[0.54,
4.82],
P Z 0.39
I2 Z 60%,
P Z 0.06
7 0.88
[0.46,
1.69],
P Z 0.71
I2 Z 55%,
P Z 0.04
MeH
Random
1.71 0.35 1.72 0.09
(continued on next page)
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Table 2 (continued)
Long-term
outcome
Comparison Randomized studies Non-Randomized studies Total
Number
of
studies
Subtotal
OR
Heterogeneity Number
of
studies
Subtotal
OR
Heterogeneity Number
of
studies
Total OR Hetero eneity Analysis
method
Publication
bias
Test for
subgroup
differences
coef p value z-test p value
Recurrent
Carotid
Artery
Stenosis
ECEA
vs CCEA
5 0.56
[0.35,
0.89],
P [ 0.01
I2 Z 0%,
P Z 0.47
12 0.59
[0.26,
1.35],
P Z 0.21
I2 Z 90%,
P < 0.001
17 0.56
[0.29,
1.09],
P Z 0.09
I2 Z 8 %,
P < 0. 01
MeH
Random
2.7 0.02 0.11 0.91
ECEA
vs PCEA
3 0.87
[0.40,
1.93],
P Z 0.74
I2 Z 0%,
P Z 0.50
7 0.77
[0.26,
2.33],
P Z 0.65
I2 Z 86%,
P < 0.001
10 0.73
[0.31,
1.70],
P Z 0.47
I2 Z 7 %,
P < 0. 01
MeH
Random
0.3 0.85 0.18 0.86
Late
Carotid
Artery
Occlusion
ECEA
vs CCEA
4 0.24
[0.08,
0.72],
P Z 0.01
I2 Z 53%,
P Z 0.12
4 0.68
[0.31,
1.46],
P Z 0.32
I2 Z 27%,
P Z 0.25
8 0.48
[0.25,
0.90],
P Z 0.02
I2 Z 4 %,
P Z 0 0
Peto
Fixed
0.1 0.94 1.52 0.13
ECEA
vs PCEA
2 0.07
[0.00,
1.31],
P Z 0.08
Not
applicable
2 2.27
[0.37,
14.04],
P Z 0.38
I2 Z 0%,
P Z 0.35
4 0.66
[0.05,
8.04],
P Z 0.75
I2 Z 6 %,
P Z 0 8
MeH
Random
5.8 0.48 1.99 0.05
Late Stroke ECEA
vs CCEA
4 0.83
[0.43,
1.63],
P Z 0.60
I2 Z 1%,
P Z 0.36
6 0.83
[0.43,
1.58],
P Z 0.57
I2 Z 57%,
P Z 0.13
10 0.83
[0.52,
1.32],
P Z 0.43
I2 Z 8 ,
P Z 0 6
Peto
Fixed
0.4 0.53 0 1.00
ECEA
vs PCEA
3 0.97
[0.06,
15.47],
P Z 0.98
I2 Z 50%,
P Z 0.16
5 0.15
[0.02,
1.48],
P Z 0.10
Not
applicable
8 0.32
[0.06,
1.86],
P Z 0.20
I2 Z 3 %,
P Z 0 2
Peto
Fixed
0.4 0.53 1.04 0.30
Late
mortality
ECEA
vs CCEA
5 0.82
[0.63,
1.07],
P Z 0.14
I2 Z 0%,
P Z 1.00
6 0.66
[0.45,
0.94],
P Z 0.02
I2 Z 59%,
P Z 0.09
11 0.76
[0.61,
0.94],
P Z 0.001
I2 Z 0 ,
P Z 0 5
Peto
Fixed
1.2 0.24 0.94 0.35
ECEA
vs PCEA
3 0.80
[0.52,
1.22],
P Z 0.30
I2 Z 0%,
P Z 1.00
4 0.36
[0.18,
0.72],
P Z 0.004
Not
applicable
7 0.64
[0.44,
0.92],
P Z 0.02
I2 Z 1 %,
P Z 0 0
Peto
Fixed
1.2 0.24 1.92 0.05
Abbreviations: Eversion Carotid Endarterectomy: ECEA, Conventional Carotid Endarterectomy: CCEA, Odds Ratio: OR, Confidence Int val: CI, coef: coefficient.
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Figure 4 Forest plot presenting the meta-analysis based on ORs for the association between Eversion Carotid Endarterectomy vs.
Conventional Carotid Endarterectomy and risk for late carotid artery occlusion. ORs in the individual studies are presented as
squares with 95%CIs presented as extending lines. The pooled OR with its 95%CI is depicted as a diamond.
Figure 5 Forest plot presenting the meta-analysis based on ORs for the association between Eversion Carotid Endarterectomy vs.
Conventional Carotid Endarterectomy and risk for late mortality. ORs in the individual studies are presented as squares with 95%CIs
presented as extending lines. The pooled OR with its 95%CI is depicted as a diamond.
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